Subscribe to RSS

DOI: 10.1590/0004-282X20190179
Cerebrospinal fluid challenges for the diagnosis of herpes simplex infection in the central nervous system
Desafios do exame do líquido cefalorraquidiano para o diagnóstico de infecção por herpes simplex no sistema nervoso central
Abstract
Herpes simplex virus (HSV) is a cause of a severe disease of the central nervous system (CNS) in humans. The demonstration of specific antibodies in the cerebrospinal fluid (CSF) may contribute to the retrospective neurological diagnosis. However, the commercial immunological tests for HSV infection are for use in serum samples. Objective: The aim of the present study was to adapt a commercial kit anti-HSV IgG used for serum samples to be performed with a CSF sample. Methods: Forty CSF specimens from 38 patients with suspected CNS HSV infection were serially diluted for detecting anti-HSV IgG by enzyme immunoassay (EIA). The same samples were also analyzed with the polymerase chain reaction (PCR). Results: The sensitivity of EIA test for HSV was 5% (dilution 1:40) and 65% (dilution 1:2) in CSF, and HSV DNA PCR was 15%. The combined analysis of EIA (dilution 1:2) and PCR increased the sensitivity up to 72.5%. The inflammatory CSF was associated with positive HSV PCR. Conclusions: We demonstrated the importance to adapt serological anti-HSV IgG EIA test for CSF assays to increase the accuracy of the analysis, considering the low concentration of specific antibodies in CSF.
Resumo
O vírus herpes simples (HSV) é um dos agentes causadores de uma doença grave no sistema nervoso central (SNC) em humanos. A detecção de anticorpos específicos no líquido cefalorraquidiano (LCR) pode contribuir para o diagnóstico neurológico retrospectivo. Entretanto, os testes imunológicos comerciais são para uso em amostras de soro. Objetivo: Adaptar um kit comercial sorológico anti-HSV IgG para ser utilizado no de LCR. Metodos: Quarenta amostras de LCR de 38 pacientes com suspeita de infecção por HSV no SNC foram diluídas pesquisa de anticorpos anti-HSV IgG pelo método imunoenzimático (EIA). Além disso, as mesmas amostras também foram analisadas por reação em cadeia da polimerase (PCR). Resultados: A sensibilidade do teste EIA para o HSV consistiu em 5% (diluição 1:40) e 65% (diluição 1:2) no LCR, e o PCR do DNA do HSV, 15%. A análise combinada de EIA (diluição 1:2) e PCR aumentou a sensibilidade para 72,5%. Houve associação entre presença do LCR inflamatório e PCR positiva para HSV. Conclusões: Demonstramos a importância na adaptação previa do teste sorológico anti-HSV IgG EIA para ensaios do no LCR, a fim de aumentar a acuracia da análise, considerando a baixa concentração de anticorpos específicos no LCR.
Keywords:
herpes simplex virus - cerebrospinal fluid - enzyme immunoassay - polymerase chain reactionPalavras-chave:
simplex virus - líquido cefalorraquidiano - técnicas imunoenzimáticas - reação em cadeia da polimerasePublication History
Received: 03 September 2019
Accepted: 24 November 2019
Article published online:
02 June 2023
© 2020. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Ryu W. Herpesviruses. In: Ryu W, Molecular Virology of Human Pathogenic Viruses. London: ELSEVIER; 2017. p.125-39.
- 2 Patoulias D, Koutras C. HSV encephalitis: is the insight of the clinician still crucial for the outcome? Folia Med Cracov. 2017;57(4):97-105.
- 3 Soares BP, Provenzale JM. Imaging of Herpes virus Infections of the CNS. AJR Am J Roentgenol. 2016 Jan;206(1):39-48. https://doi.org/10.2214/AJR.15.15314
- 4 Hogestyn JM, Mock DJ, Mayer-Proschel M. Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology. Neural Regen Res. 2018 Feb;13(2):211-21. https://doi.org/10.4103/1673-5374.226380
- 5 Adler AC, Kadimi S, Apaloo C, Marcu C. Herpes simplex encephalitis with two false-negative cerebrospinal fluid PCR tests and review of negative PCR results in the clinical setting. Case Rep Neurol. 2011 May/Aug;3(2):172-8. https://doi.org/10.1159/000330298
- 6 Akçali A, Ozkaya E, Yilmaz D, Uyar Y, Oncül O. Investigation of herpes simplex virus in viral meningoencephalitis suspected cases using molecular and serological methods. Mikrobiyol Bul. 2008 Jul;42(3):421-8.
- 7 Studahl M, Lindquist L, Eriksson BM, Günther G, Bengner M, Franzen-Röhl E, et al. Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management. Drugs. 2013 Feb;73(2):131-58. https://doi.org/10.1007/s40265-013-0007-5
- 8 Agência Nacional de Vigilância Sanitária (ANVISA). Brasil. Ministério da Saúde ICdBL. Resolução nº 899, 29 de maio de 2003, determina a publicação do “Guia para a validação de métodos analíticos e bioanalíticos”. Available from: http://portal.anvisa.gov.br/documents/10181/2718376/RE_899_2003_COMP.pdf/ff6fdc6b-3ad1-4d0f-9af2-3625422e6f4b
- 9 Kawada J, Kimura H, Ito Y, Hoshino Y, Tanaka-Kitajima N, Ando Y, Futamura M, Morishima T. Comparison of real-time and nested PCR assays for detection of herpes simplex virus DNA. Microbiol Immunol. 2004;48(5):411-5. https://doi.org/10.1111/j.1348-0421.2004.tb03530.x
- 10 Nielsen KE, Knudsen TB. Elsberg syndrome. Ugeskr Laeger. 2013 Dec;175(51):pii:V01130085.
- 11 Steiner I, Benninger F. Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep. 2013 Dec;13(12):414. https://doi.org/10.1007/s11910-013-0414-8
- 12 Agência Nacional de Vigilância Sanitária (ANVISA). Brasil. Ministério da Saúde. Resolução da Diretoria Colegiada - RDC Nº. 302, de 13 de outubro de 2005. Brasília: Ministério da Saúde.
- 13 Ward KN, Ohrling A, Bryant NJ, Bowley JS, Ross EM, Verity Cm. Herpes simplex serious neurological disease in young children: incidence and long-term outcome. Arch Dis Child. 2012;97(2):162-5. http://dx.doi.org/10.1136/adc.2010.204677
- 14 Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006 Sep;71(2-3):141-8. https://doi.org/10.1016/j.antiviral.2006.04.002
- 15 Riera-Mestre A, Gubieras L, Martínez-Yelamos S, Cabellos C, Fernández-Viladrich P. Adult herpes simplex encephalitis: fifteen years' experience. Enferm Infecc Microbiol Clin. 2009 Mar;27(3):143-7. https://doi.org/10.1016/j.eimc.2008.05.006
- 16 Denes E, Labach C, Durox H, Adoukonou T, Weinbreck P, Magy L, et al. Intrathecal synthesis of specific antibodies as a marker of herpes simplex encephalitis in patients with negative PCR. Swiss Med Wkly. 2010 Oct;140:w13107. https://doi.org/10.4414/smw.2010.13107
- 17 Kamei S, Takasu T, Morishima T, Mizutani T. Serial changes of intrathecal viral loads evaluated by chemiluminescence assay and nested PCR with aciclovir treatment in herpes simplex virus encephalitis. Intern Med. 2004 Sep;43(9):796-801. https://doi.org/10.2169/internalmedicine.43.796
- 18 Tyler KL. Update on herpes simplex encephalitis. Rev Neurol Dis. 2004 Fall;1(4):169-78.